Page last updated: 2024-10-22

acetyl-dl-leucine and Parkinson Disease

acetyl-dl-leucine has been researched along with Parkinson Disease in 1 studies

acetylleucine: used for treating vestibular-related imbalance and vertigo

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Xu, Z1
Lian, C1
Pan, L1
Lai, W1
Zhang, F1
Peng, L1
Zhou, S1
Zhao, G1
Yang, X1
Zhang, G1
Tan, Z1
Wang, Y1

Other Studies

1 other study available for acetyl-dl-leucine and Parkinson Disease

ArticleYear
N-acetyl-L-leucine protects MPTP-treated Parkinson's disease mouse models by suppressing Desulfobacterota via the gut-brain axis.
    Brain research bulletin, 2023, 10-01, Volume: 202

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain-Gut Axis; Disease Models, Animal; Dopam

2023